Trezen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trezen

Understanding Trezen

Trezen is a pharmacological treatment utilized in the management of specific gastrointestinal conditions. It belongs to a class of medications designed to modulate the movement and function of the digestive tract. By acting on specific receptors within the gut, it helps regulate the transit time of material through the intestines.

Therapeutic Purpose

The primary function of Trezen is to alleviate chronic symptoms associated with bowel irregularity. It is typically considered for individuals who have not achieved adequate relief from lifestyle modifications or over-the-counter interventions. The medication works by enhancing the natural processes of the digestive system to facilitate more consistent bowel movements.

Mechanism of Action

At a physiological level, Trezen interacts with the nervous system signals that govern the muscles of the intestinal wall. By stimulating these pathways, the medication promotes peristalsis—the wave-like muscle contractions that move content through the colon. This mechanism is intended to reduce the discomfort and physical strain often associated with impaired gastrointestinal motility.

Regulatory References

  1. NIH MedlinePlus: ACE Inhibitors

What side effects are possible with Trezen?

Possible Side Effects and Safety Information

The safety profile of Trezen (Perindopril) is officially structured around the common characteristics of Angiotensin-Converting Enzyme (ACE) inhibitors. Adverse reactions are classified by frequency and by affected physiological systems, as documented by regulatory agencies.


Adverse Reaction Categories

Side effects documented in regulatory labeling are classified into frequency categories:

  • Most Common (e.g., in US labeling): Include a persistent, non-productive cough, dizziness, and back pain.
  • Common: Include headache, vertigo, nausea, and muscle cramps.
  • Uncommon to Rare: Include an excessive drop in blood pressure (hypotension), sleep disturbances, and hypersensitivity reactions.

These effects are formally grouped into System-Organ Classes such as Vascular Disorders, Respiratory Disorders, and Nervous System Disorders.


Serious Adverse Reactions and Restrictions

Official labeling highlights several serious adverse reactions and strict safety constraints:

  • Serious Adverse Reactions include the risk of Angioedema (rapid swelling of the face, tongue, and throat, which can cause airway obstruction), and Acute Renal Failure. The risk of Angioedema has been reported to occur at any time during treatment.
  • Population Constraints: Trezen is contraindicated for use during the second and third trimesters of pregnancy due to the confirmed risk of fetal toxicity.
  • Safety Restrictions: The medicine is contraindicated in patients with a history of Angioedema related to previous ACE inhibitor use and in individuals using the combination medicine Sacubitril/Valsartan.
  • Time-Related Patterns: Symptomatic Hypotension is explicitly noted as a risk that is more likely to occur following the initiation of therapy, especially in patients with a highly activated Renin-Angiotensin-Aldosterone System (RAAS).

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation states that the most likely clinical manifestation of a Trezen (Perindopril) overdose is severe hypotension (extremely low blood pressure), which may present with dizziness and faintness.

Documented Overdose Outcomes and Actions

Classification Official Regulatory Statement
Severe Outcomes Overdose carries the risk of circulatory shock, acute renal failure, and disturbances in salt and water balance. An excessive fall in blood pressure may result in a myocardial infarction or cerebrovascular accident in susceptible patients.
Emergency Action Seek immediate medical attention or call emergency services if overdose is suspected, especially if the person has collapsed, has trouble breathing, or cannot be awakened. Contacting Poison Control is also required.

Management and Monitoring

No specific antidote is known for Perindopril overdose, and treatment is defined as being symptomatic and supportive. Regulatory instructions mandate the immediate discontinuation of the medication. If severe hypotension occurs, the patient should be placed in a supine position and may require an intravenous infusion of physiological saline solution to restore blood volume. The active metabolite, Perindoprilat, is documented as removable by hemodialysis.

Therapeutic Uses of Trezen

What Trezen Treats: Main Uses and Benefits

Trezen (Perindopril) is commonly used across three major therapeutic domains associated with systemic imbalance and cardiovascular functional stress. Its applications focus on systemic stabilization and therapeutic protection.

Essential Management of Chronic High Blood Pressure

Trezen is used for managing long-term high blood pressure (hypertension), a chronic condition where heightened physiological activity often causes no immediate symptoms but creates noticeable physiological strain. This continuous therapy generally assists with maintaining functional stability by managing pressure levels. This is commonly used to help with conditions marked by increased physiological stress.

Support for Chronic Heart Failure Symptoms

The medication is applied in addressing symptoms related to systemic imbalance, such as heart failure. It helps address symptom clusters that may appear suddenly or fluctuate, including shortness of breath and fatigue during activity, as well as swelling (edema) in the extremities. This support generally contributes to easing the overall symptom load, which assists with maintaining functional stability during symptomatic periods.

Protection After Heart Events

Trezen is applied in clinical settings that involve chronic or unstable symptom patterns, such as Stable Coronary Artery Disease and for patients after experiencing a major cardiovascular event. This long-term use is applied in scenarios where additional management of discomfort and systemic stress is required. The therapy supports general well-being during these symptomatic phases and may assist with managing symptoms that interfere with daily comfort.


Quick Fact: Therapeutic Domains

Trezen is commonly used to help with conditions presenting with acute episodes, supporting patients during difficult episodes by easing distress related to chronic hypertension, heart failure symptoms, and post-event cardiovascular stabilization.

Regulatory References

  1. Summary of Product Characteristics (HPRA)

Eligibility and Restrictions for Use

Who Can and Cannot Use Trezen?

The official regulatory profile for Trezen (Perindopril) defines strict population-based eligibility for its use, primarily classifying patients into contraindicated, restricted, or allowed groups.

Absolute Prohibitions

Use is contraindicated for any patient with a history of angioedema (hereditary, idiopathic, or related to any previous ACE inhibitor therapy) or known hypersensitivity to any ACE inhibitor. Trezen is absolutely prohibited during the second and third trimesters of pregnancy due to the high risk of fetal toxicity. Furthermore, the medicine must not be used concurrently with a neprilysin inhibitor (like Sacubitril/Valsartan) or with Aliskiren in patients diagnosed with diabetes mellitus or renal impairment.

Restricted and Conditional Use

Trezen is approved for use in adults, including older adults, though renal function must be considered. Use in children and adolescents (under 18 years) is not recommended because safety and effectiveness in this pediatric population have not been established by regulatory authorities. The drug is not recommended for women in the first trimester of pregnancy or while breastfeeding. Severe renal impairment (creatinine clearance less than 30 mL/min) and severe hepatic impairment are also conditions where use is officially restricted or not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Trezen (Perindopril) around combinations that are strictly restricted or contraindicated due to risks associated with additive physiological effects or reduced drug clearance.

Prohibited Combinations and Constraints

Combination Type Restriction/Mechanism
Sacubitril/Valsartan Contraindicated due to significantly increased risk of angioedema. Requires a mandatory 36-hour separation period.
Aliskiren Contraindicated in patients with diabetes or impaired renal function (GFR <60 mL/min/1.73 m²) due to heightened risk of hyperkalaemia and renal dysfunction.
Extracorporeal Treatments Contraindicated with specific procedures (e.g., certain dialysis membranes) due to risk of severe anaphylactoid reactions.

Clinically Significant Pharmacodynamic Effects

Co-administration with several substance classes can result in an additive physiological impact as defined in regulatory labels:

  • Potassium-Sparing Diuretics (e.g., spironolactone) and Potassium Supplements officially increase the risk of hyperkalaemia (high serum potassium).
  • NSAIDs can officially reduce the drug’s antihypertensive effect and increase the risk of renal function deterioration.
  • Antidiabetic Agents may cause an increased blood-glucose lowering effect, creating a risk of hypoglycemia.
  • Lithium clearance is reduced by Trezen, resulting in increased serum lithium concentrations and potential toxicity.

Alcohol (Ethanol) may have an additive effect on lowering blood pressure. Furthermore, elderly patients are officially noted to have higher plasma concentrations of the active metabolite due to reduced clearance, influencing overall interaction risk.

Mechanism of Action

How Trezen Works


Modulation of Serotonin Reuptake

Trezen works primarily by acting within domains involving neurotransmitter transporter-mediated signaling. It selectively inhibits the reuptake of serotonin (5-HT) by blocking the serotonin transporter (SERT), modifying an early molecular step that shapes systemic physiological outcomes. This initiates a signaling sequence that leads to enhanced and prolonged serotonergic activity in the central nervous system, resulting in increased occupancy of the serotonin transporter (SERT) and reduced 5-HT clearance.


Multimodal Receptor Engagement

The drug also engages mechanisms that influence overactive or dysregulated processes through direct interaction with specific neurotransmitter receptors. It possesses high-affinity binding to multiple serotonin receptors, acting as both an agonist (like at 5-HT1A) and an antagonist (like at 5-HT3 and 5-HT7). This unique multimodal activity, in conjunction with the reuptake inhibition, modifies the net effect on downstream signaling and influences signaling through specific 5-HT receptor subtypes.

Dosage and Administration Information

How to Use Trezen

Trezen, containing Perindopril, is utilized via oral administration in the form of tablets. Official usage is structured around specific starting doses and titration protocols, defining how the medicine is taken over time.


Official Administration Guidelines

The standard frequency for Trezen is once daily, although for hypertension maintenance, the dosage may be administered in two divided doses. Administration is recommended in the morning before a meal to optimize the conversion to the active substance, Perindoprilat.

Indication Initial Dose (Once Daily) Maintenance Dose (Once Daily) Maximum Dose
Hypertension 4 mg 4 mg to 8 mg 16 mg
Stable CAD 4 mg (for 2 weeks) 8 mg 8 mg

Usage Patterns and Adjustments

Treatment begins with a low initial dose and generally involves a titration period, such as the two-week initial phase required before increasing the dose for Stable Coronary Artery Disease.

Specific adjustments are mandated for certain patient groups. For older adults (over 70) being treated for Stable CAD, a lower starting dose of 2 mg daily is required for the first week, followed by 4 mg in the second week, before reaching the 8 mg maintenance dose. For individuals with renal impairment (CrCl ≥ 30 mL/min), the initial dose must be limited to 2 mg per day, with a maximum of 8 mg per day. The medicine is not recommended for use in children and adolescents, as safety and efficacy have not been established.

Recent Clinical Evidence

Research on Trezen (Perindopril) has explored its effect in three main clinical situations: chronic high blood pressure, stable coronary artery disease, and chronic heart failure symptoms. Large-scale Randomized Controlled Trials (RCTs) and meta-analyses examined its use in populations with chronic high blood pressure (hypertension), tracking changes in systolic and diastolic blood pressure, as well as the occurrence of major cardiovascular events like stroke and non-fatal heart attack.

Further long-term RCTs concentrated on patients with Stable Coronary Artery Disease, particularly those with a history of heart events. In these studies, the central measure was a composite endpoint tracking cardiovascular death, heart attack, and resuscitated cardiac arrest. Separately, studies monitored functional and symptomatic outcomes in patients with chronic heart failure, often focusing on the elderly and changes in their ability to perform daily activities.

Research describes that patterns related to outcomes were observed over several years in the larger trials, though long-term effects are not fully established for all subgroups. Studies also evaluated Perindopril in specific patient groups, including older adults (over 70) and those with coexisting conditions like diabetes.

Limitations across the research base include the finding that some long-term outcomes rely on trials that were statistically underpowered or faced patient withdrawal, which reduces the reliability of the follow-up data. Data for specific monotherapy use and certain complex patient characteristics remain insufficient, and comparative evidence is lacking in some scenarios, meaning research is limited for a complete picture.

Frequently Asked Questions (FAQ)

Common questions about Trezen (FAQ)


Q: Is Trezen considered a long-term treatment or is it for short-term use?

A: Official documentation describes the use of Trezen as being for the long-term management of chronic health conditions. This includes chronic high blood pressure and stable coronary artery disease, that may require periodic review by a healthcare provider.


Q: Is it common to feel tired or dizzy when taking Trezen?

A: Dizziness is listed as a common adverse reaction in official safety documents. Tiredness may also be reported as a side effect, and this is sometimes associated with a drop in blood pressure that can occur with the medication.


Q: Can Trezen affect sleep patterns?

A: Official regulatory documents indicate that sleep disturbances are reported as an uncommon to rare side effect of Trezen.


Q: Can Trezen be taken alongside common over-the-counter pain relievers?

A: Official guidance notes that a major class of pain relievers, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), can affect how Trezen works. Since different over-the-counter (OTC) products may contain various ingredients, official guidance often highlights the importance of discussing all OTC drugs with a clinician.


Q: Are there any major food or drink items, like grapefruit, that interact with Trezen?

A: Official product information notes that administration is suggested before a meal because food intake can alter how the drug is processed in the body. Specific interactions with food items like grapefruit juice are not typically detailed in major regulatory labels.


Q: Is Trezen known to affect liver or kidney function?

A: The medicine is known to affect the kidneys, and dose adjustments are noted as necessary for certain types of renal impairment. Serious symptoms requiring medical evaluation, such as signs of liver problems (e.g., jaundice), are also listed in the drug’s safety information.


Q: Can Trezen make certain existing conditions worse?

A: Regulatory documents state that Trezen is contraindicated (its use is precluded) or requires specific caution in patients with certain pre-existing conditions. These include a history of angioedema related to an ACE inhibitor, and specific types of renal impairment or kidney disease.


Q: Does Trezen require a special prescription or monitoring program?

A: Trezen is available as a prescription-only drug. Monitoring of certain blood components, such as serum electrolytes and renal function (kidney function), is officially recommended and is noted as necessary for periodic review.


Q: What are the primary safety warnings for Trezen outlined by the FDA?

A: The US Food and Drug Administration (FDA) label includes a Boxed Warning regarding fetal toxicity. If a patient becomes pregnant, official guidance requires the drug's discontinuation as soon as possible due to the confirmed risk of injury and death to the developing fetus.


Q: How does Trezen interact with common cold or allergy medications?

A: Regulatory guidance suggests discussing the use of over-the-counter cough or cold drugs with a clinician. These products may contain ingredients, such as certain decongestants, that have the potential to raise blood pressure, which could interfere with Trezen’s function.


Q: Is Trezen a type of opioid or controlled substance?

A: Official documents classify Trezen as an Angiotensin-Converting Enzyme (ACE) inhibitor, which is a type of blood pressure medicine. It is available only with a prescription and is not classified as an opioid or controlled substance in regulatory texts.


Q: How quickly does Trezen start to work after the first dose?

A: Pharmacology studies indicate that the active metabolite of Trezen typically reaches peak concentrations within 2–3 hours. Maximal ACE inhibition (when the drug is fully blocking the target enzyme) is generally observed 4–6 hours after administration.


Q: What is the expected duration of Trezen's effects?

A: Trezen is generally utilized via once-daily dosing. The inhibition of the ACE enzyme is described in studies as being substantial, persisting beyond 24 hours. This sustained action is what provides adequate long-term treatment for conditions like high blood pressure.


Q: Can Trezen be taken with supplements or herbal products?

A: Official guidance notes that there is often very limited information available regarding the safety of combining Trezen with specific supplements or herbal products. For this reason, official guidance often highlights the importance of discussing all supplements with a healthcare provider.


Q: Does Trezen come in a generic version?

A: Yes, the active ingredient in Trezen, perindopril erbumine, has been authorized by regulatory bodies. It is available as a generic pharmaceutical product in certain strengths.


Q: What should a patient know if they have never taken Trezen before?

A: Regulatory information includes key precautions for new users, such as the potential for temporary dizziness or lightheadedness following the initial dose. The safety information notes the importance of reporting signs of a severe reaction like angioedema promptly.


Q: Is it normal to not feel the effects of Trezen right away?

A: Official guidance indicates this experience is common. Many individuals who take Trezen for its primary purpose (high blood pressure) often do not feel unwell before starting the treatment. Therefore, a noticeable physical sensation of the drug working may not be expected.


Q: Do I need to stop taking Trezen gradually, or can I stop suddenly?

A: Official guidance emphasizes the importance of continuing to take the drug as prescribed, even if a patient feels well. The decision to stop the medicine, which may require a specific plan, falls under the direction of a healthcare provider.


Q: Are there restrictions on taking Trezen while breastfeeding?

A: Official guidance notes that the effects of the drug on a nursing infant are unknown. Some regulatory authorities do not recommend use while breastfeeding, and caution is advised for this population.


Q: What is the risk of dependence or addiction with Trezen?

A: Trezen is classified as an Angiotensin-Converting Enzyme (ACE) inhibitor. The official safety profile for this class of medicine does not list a risk of dependence or addiction.


Q: Does Trezen change how other medications are absorbed?

A: The conversion of Trezen to its active form is influenced by factors like food intake. Regulatory documents primarily focus on pharmacodynamic interactions (changes in the effect of other drugs) and clearance rather than changes in the systemic absorption of other medicines.


Q: Can Trezen cause changes in mood or anxiety?

A: Official documentation includes anxiety and psychosexual disorders among the reported psychiatric side effects.


Q: Can I drive or operate machinery while taking Trezen?

A: Official safety documents indicate that activities such as driving a car or operating machinery should be avoided if a patient experiences certain side effects. These include temporary symptoms such as dizziness or blurred vision.


Q: What information should I give my healthcare provider before starting Trezen?

A: Official guidance states that information provided to the healthcare provider should include details about any allergies, a history of angioedema, any existing kidney disease, and all current medications (prescription, over-the-counter, and supplements).


Q: Is there a maximum time frame for using Trezen as listed in the prescribing information?

A: There is no explicit maximum time limit defined in the prescribing information. The drug is described as being appropriate for the long-term management of chronic conditions.


Q: Does Trezen require any special monitoring or lab tests?

A: Trezen is a prescription medicine. Monitoring of certain blood components, such as serum electrolytes and renal function (kidney function), is officially recommended and is noted as necessary for periodic review.

How should Trezen be stored and disposed of?

How to Store and Dispose of Trezen?

Storage Requirements

Trezen (Perindopril) tablets must be stored at controlled room temperature, generally between 20°C and 25°C (68°F and 77°F), as stated in official labeling. Storage conditions must ensure the product is protected from moisture and light. It is mandatory to keep the medication in its original container and ensure the container is tightly closed when not in use. For stability, certain presentations may have a documented six-month shelf-life after first opening, provided the container remains tightly sealed.

Disposal and Child Safety

All medication must be kept out of the sight and reach of children and pets. Unused or expired Trezen must be disposed of according to local regulations, with the primary recommendation being to use a drug take-back program. It is explicitly mandated that the medicine must not be discarded via wastewater or the municipal sewage system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trezen found in:

A-Z Index: